주식/증권
📈 긍정적
LivaNova Q2 Earnings & Revenues Beat Estimates, '26 Outlook Raised
요약
LIVN's Q2 earnings and revenues beat estimates as Cardiopulmonary and Epilepsy growth fuels margin gains and a raised 2026 outlook.